The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

Clinical trial NCT06118723 · RECRUITING

Trial details

NCT number: NCT06118723
Sponsor: Jasper Gerritsen
Status: RECRUITING
Study type: OBSERVATIONAL

Glioblastoma High-grade Glioma Glioblastoma, IDH-wildtype Glioblastoma, IDH-mutant Glioblastoma Multiforme, Adult Astrocytoma, Grade IV Astrocytoma, Grade III Astrocytoma, Malignant Brain Neoplasms Brain Neoplasm, Primary Brain Neoplasms, Adult Brain Neoplasm, Malignant

Start date: 2022-01-01
Primary completion: 2027-01-01
Enrollment: 784

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.